Loading...
Market
Will Oxford University's Marburg virus vaccine pass Phase 1 human trials by December 31, 2024?
4
Resolution / Starting Odds
Yes • 50%
No • 50%
Official announcements from Oxford University or reputable news sources such as BBC
Story
Oxford University Begins Human Testing of Marburg Virus Vaccine on July 12: BBC
Jul 12, 2024, 05:04 AM
Scientists at Oxford University have commenced human testing of a vaccine for the Marburg virus on July 12. This development, reported by BBC, marks a significant step in combating the deadly virus, which has been a concern for global health authorities due to its high mortality rate and potential for outbreaks. The Marburg virus is related to the Ebola virus and causes severe hemorrhagic fever in humans. The vaccine aims to provide immunity and prevent future outbreaks, contributing to global health security.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
United Kingdom • 25%
European Union • 25%
United States • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Successful with no major side effects • 25%
Successful with some side effects • 25%
Unsuccessful • 25%
Inconclusive • 25%
